We are the most humanoid-explicit neighbour — 16 mentions in our filing against zero for one peer — and we have built ZSHF-11 and ZSHD-14 harmonic joints plus dexterous-hand reducers, but they are developed and sampling, not booked revenue. Our reducer slice, 24.2% of sales, remains overwhelmingly industrial robots, and we name no humanoid OEM at primary. We relay a third-party $1B-to-$15B demand frame as attributed, not ours, and we carry humanoid industrialisation falling short as a formal risk on the same page.